Filing Details
Sagimet Biosciences Inc. (NASDAQ:SGMT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:SGMT
Sagimet Biosciences Inc. (SGMT) Files Quarterly Report for Q0
Sagimet Biosciences Inc. (NASDAQ:SGMT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Sagimet Biosciences Inc. (NASDAQ:SGMT) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Sagimet Biosciences Inc. (NASDAQ: SGMT) filed its quarterly report (Form 10-Q) on August 11, 2026, providing unaudited financial statements and management commentary for Q0.
- The company's stock trades at $9.52 with a market capitalization of $196.9 million.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions, though it is less detailed than the annual 10-K report.
Market Context
Sagimet Biosciences Inc.'s stock currently trades at $9.52 with a market capitalization of $196.9M.
The 10-Q provides Sagimet Biosciences Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Sagimet Biosciences Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SGMT Stock Page
Frequently Asked Questions
Where can I read SGMT's SEC filings?
Browse all filings on our SGMT SEC filings page.
What types of SEC filings does Sagimet Biosciences Inc. file?
Public companies like Sagimet Biosciences Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.